View Article

Abstract

Microneedle (MN) technology represents a promising, minimally invasive approach for transdermal drug delivery, combining the benefits of injections and patches while minimizing pain and tissue damage. Herbal extracts and phytoconstituents, known for their antioxidant, anti-inflammatory, antimicrobial, and anticancer properties, often face challenges such as poor solubility, instability, and limited bioavailability. Conventional oral and topical formulations are inadequate due to the skin’s barrier function and hepatic first-pass metabolism. Integrating MN technology with herbal drug delivery provides an innovative solution by creating transient microchannels in the skin, enhancing permeability, and allowing controlled, sustained release of phytochemicals. Recent studies have successfully incorporated compounds such as curcumin, resveratrol, mangiferin, and quercetin into dissolving, hydrogel, and stimuli-responsive MN systems. These formulations improved dermal absorption, therapeutic efficacy, and multifunctional outcomes, including wound healing and targeted anticancer activity. Furthermore, nanocarrier-based MN systems—utilizing nanoparticles, nanocrystals, or lipid carriers—have shown potential to increase stability and bioavailability of plant-derived molecules. Despite these advances, the field remains in early development, with challenges in large-scale production, standardization, and regulatory approval. Addressing safety, stability, and patient compliance is essential for translating microneedle-assisted herbal drug delivery into practical and clinically accepted therapies.

Keywords

Microneedle technology, Herbal drug delivery, Phytoconstituents, Transdermal Therapy, Nanocarriers.

Introduction

Microneedle (MN) technology is a minimally invasive transdermal drug delivery approach that combines the benefits of hypodermic injections and transdermal patches while reducing pain and tissue damage [1]. By forming microscopic pores in the skin, MNs effectively bypass the stratum corneum barrier, enhancing the permeation of both small and large drug molecules [2]. This technology is particularly advantageous for herbal extracts and phytoconstituents, which often exhibit poor solubility, chemical instability, and limited oral bioavailability due to gastrointestinal degradation and first-pass metabolism [3]. Conventional herbal formulations such as creams, gels, and oral dosage forms generally produce low therapeutic efficacy, restricting their clinical applicability [4]. Incorporating phytoconstituents into MN systems enhances drug absorption, prolongs therapeutic activity, and improves patient compliance by integrating traditional herbal medicine with modern delivery technologies [5].

Several studies have reported successful incorporation of phytochemicals such as curcumin, resveratrol, and mangiferin into MN platforms [6]. Curcumin-loaded dissolving MNs demonstrated improved skin deposition, controlled release, and superior wound healing and anticancer effects [4]. Likewise, resveratrol-loaded MNs achieved enhanced local delivery, anti-inflammatory action, and metabolic regulation [7]. Mangiferin-loaded ROS/pH-responsive MNs allowed controlled release for infected wound therapy [5]. These systems overcome solubility and permeability barriers associated with phytoconstituents and provide multifunctional drug delivery potential [6]. However, most investigations remain at the preclinical level, with further studies needed on large-scale production, stability, and regulatory considerations [1]. Overall, MN-assisted delivery of herbal extracts represents a promising frontier in transdermal phytomedicine [7].

Figure 1 : Microneedle bridge the gap between traditional herbal medicine and modern drug delivery

NEED OF THE WORK

Despite their extensive use in traditional medicine, herbal extracts and phytoconstituents face major challenges in modern therapeutics due to poor aqueous solubility, chemical instability, rapid metabolism, and limited systemic absorption following oral administration [8]. Even with topical application, the stratum corneum acts as a strong barrier that restricts the penetration of large or hydrophilic phytomolecules such as flavonoids, polyphenols, and alkaloids, resulting in subtherapeutic concentrations at the target site [9]. Conventional dosage forms, including creams, gels, and patches, often fail to provide adequate drug penetration, limiting their clinical efficacy [10].

Transdermal drug delivery offers several advantages, such as bypassing hepatic first-pass metabolism, providing sustained release, and improving patient compliance; however, its success relies on overcoming the skin’s barrier properties [11]. Microneedles (MNs) have emerged as an innovative solution by creating transient microchannels that permit efficient transport of herbal compounds into deeper skin layers without pain or tissue injury [12].

Recent studies have demonstrated that MN-mediated delivery of phytoconstituents such as curcumin, resveratrol, and mangiferin significantly enhances dermal deposition, pharmacological activity, and controlled release compared to conventional systems [13–15]. Curcumin-loaded dissolving MNs show superior wound healing and anticancer efficacy [13], resveratrol nanocrystal MNs improve dermal delivery and anti-inflammatory effects [14], and ROS/pH-responsive mangiferin MNs provide controlled release for infected wound therapy [15].

However, most studies remain at the preclinical or proof-of-concept stage, and challenges related to large-scale manufacturing, stability, patient acceptability, and regulatory approval persist [16,17]. Addressing these issues is essential to translate the pharmacological benefits of herbal compounds into clinically viable therapies. Therefore, a comprehensive review of microneedle-assisted delivery of herbal extracts and phytoconstituents is required to summarize current progress, highlight limitations, and identify future directions [18].

OBJECTIVES

The objectives of this review are formulated to provide a comprehensive understanding of microneedle-assisted delivery of herbal extracts and phytoconstituents:

  • To discuss microneedle technology in terms of design, fabrication methods, and mechanisms of skin permeation.
  • To summarize herbal extracts and phytoconstituents (such as curcumin, resveratrol, mangiferin, aloe vera, green tea polyphenols, and others) that have been successfully delivered using microneedles.
  • To analyze therapeutic applications of phytoconstituent-loaded microneedles in areas such as wound healing, cancer therapy, metabolic disorders, anti-inflammatory treatments, and dermatological conditions.
  • To evaluate the formulation strategies used to improve the stability, solubility, and release profile of phytochemicals in microneedle systems, including nanoparticles, nanocrystals, lipid carriers, and polymeric scaffolds.
  • To identify challenges and limitations in scaling up microneedle-based herbal formulations, including safety, patient acceptability, manufacturing feasibility, and regulatory perspectives.
  • To highlight future prospects of integrating nanotechnology, stimuli-responsive systems, and smart microneedle designs for enhancing herbal drug delivery.

GLYCOSIDES:

1. Glycyrrhizin:

Glycyrrhiza glabra extract, rich in glycyrrhizic acid and flavonoids, showed anti-inflammatory and antiproliferative effects when delivered via chitosan or hyaluronic acid-based microneedles, offering promising treatment for psoriasis and rheumatoid arthritis through enhanced dermal delivery and controlled release [19,20].

2. Ginsenosides:

Traditional Chinese medicine phytochemicals, such as flavonoids and saponins, exhibit poor solubility and absorption. Microneedles enhance their bioavailability and stability by bypassing first-pass metabolism, enabling efficient transdermal delivery for chronic and metabolic disorders [21].

3. Hesperetin:

A hyaluronic acid-based dissolvable microneedle patch loaded with hesperetin nanostructured lipid carriers enhanced drug stability, skin penetration, and bioavailability, offering controlled release and improved therapeutic efficacy for obesity and metabolic disorders with minimal side effects and better patient compliance.[22]

4. Emodin:

A PDA-enhanced dissolving microneedle patch loaded with emodin co-precipitate enabled rapid NIR-triggered drug release, improved skin penetration, and reduced obesity markers in rats by enhancing lipid metabolism, offering a safe, effective, and innovative approach for obesity and metabolic disorder management.[23]

5. Salicin:

Salicylic acid-loaded microneedle and hydrogel acne patches enhance drug penetration, show strong antibacterial action against P. acnes, and reduce irritation. These minimally invasive, patient-friendly systems improve treatment efficacy, stability, and cosmetic acceptability for managing various acne types effectively.[24].

6. Digoxin:

A MEMS-based hollow microneedle micropump system made of PDMS and PMMA enabled precise, painless, and controlled delivery of potent drugs like digoxin. It ensured accurate dosing, reduced infection risk, and improved safety and comfort in chronic cardiac therapy.[25]

TABLE : 1  Overview of Glycosides

Sr.No.

Phytoconstituents

Biological Source

Microneedle Application

References

1

Glycyrrhizin / Glycyrrhizic acid

Glycyrrhiza glabra (Licorice)

Treatment of psoriasis and skin disorders (via GgE-loaded chitosan microneedles) - Methotrexate delivery for rheumatoid arthritis using glycyrrhizic acid-modified carbon dots in dissolving MNs

[19,20]

2

Ginsenosides (Rg3, Rb1)

Panax ginseng

Treatment of alopecia (Rg3-liposome-loaded MNs) - Synergistic treatment of hypertrophic scars (with asiaticoside and L-carnosine)

[21]

3

Hesperidin / Hesperetin

Citrus fruits (esp. Citrus sinensis, Citrus aurantium)

Delivery of HES-loaded nanostructured lipid carriers (NLCs) via HA-based MNs for obesity and metabolic disorders

[22]

4

Emodin

Rheum tanguticum, Aloe barbadensis, Polygonum cuspidatum

Emodin-loaded dissolving MNs with PDA for enhanced fat metabolism under NIR irradiation in obesity management

[23]

5

Salicin / Salicylic Acid

Salix spp. (Willow bark), commonly used in salicylic acid form

Poly(ionic liquid)-based microneedle acne patches for direct, localized delivery - Treatment of various acne types (cystic, nodular, inflammatory)

[24]

6

Digoxin

Digitalis lanata

MEMS-based hollow microneedle integrated with micropump for precise, painless, subcutaneous/IV delivery of digoxin

[25]

FLAVANOIDS:

1. Quercetin:

Quercetin-loaded microneedles enhanced solubility, dermal penetration, and therapeutic efficacy for wounds, keloids, alopecia, and melanoma through controlled, localized release with minimal side effects. These versatile systems improved healing, angiogenesis, and antioxidant effects, offering promising potential for dermatological therapies. [26–29]

2. Luteolin:

Luteolin-loaded microneedles with colostrum-derived exosomes and propolis enable sustained ocular delivery for glaucoma, lowering intraocular pressure, improving antioxidant activity, and ensuring biocompatibility and dropless therapy with enhanced bioavailability.[30]

3. Myricetin:

Myricetin–humic acid–magnesium nanodrug microneedles exhibit photothermal, antibacterial, and antioxidant effects, promoting rapid healing of drug-resistant wounds with high biosafety, strong mechanics, and excellent infection control under NIR irradiation.[31]

TABLE: 2  Overview of Flavanoids

Sr No.

Phytoconstituent

Biological Source

Microneedle Applications

References

1

Quercetin

Camellia sinensis (tea) Theaceae

Quercetin-loaded microneedles for deeper skin delivery in wounds, scars, alopecia, melanoma.

[26-29]

2

Luteolin

Thymus vulgaris (Thyme) Lamiaceae

Luteolin-exosome microneedles for sustained, dropless ocular drug delivery in glaucoma.

[30]

3

Myricetin

Myrica gale (Sweet gale), Myrica rubra (Chinese bayberry) Myricaceae

Myricetin-loaded microneedles for drug-resistant wound healing and NIR light photothermal activation.

[31]

TERPENOIDS:

1. Oregano oil:

Oregano essential oil-loaded mucin microneedles (OEO@muMN) provide targeted, minimally invasive therapy for hypertrophic scars by reducing collagen deposition, fibroblast proliferation, and inflammation, improving scar architecture, and showing strong clinical translation potential.[32]

2. Menthol:

Menthol-enhanced microneedles improve transdermal delivery of poorly permeable drugs like asiatic acid by creating microchannels and disrupting the stratum corneum, increasing local drug retention, therapeutic efficacy, and skin penetration for dermatological applications.[33]

3. Borneol:

Borneol-loaded microneedles enhance transdermal and brain delivery of tetramethylpyrazine, improving systemic absorption, blood–brain barrier penetration, and neuroprotection in stroke models, offering a minimally invasive strategy for cardiovascular and neurological therapies.[34]

TABLE:3  Overview of Terpenoids

Sr. No.

Phytoconstituent

BIOLOGICAL SOURCE

Microneedle Application

References

1

Oregano oil

Origanum vulgare (Oregano)  Lamiaceae

Oregano oil microneedles for targeted, pain-free hypertrophic scar management.

[32]

2

Menthol

Mentha piperita (Peppermint) Lamiaceae

Menthol-hydrogel microneedles to boost transdermal delivery of pharmacological agents.

[33]

3

Borneol

Dryobalanops aromatica (Camphor tree) Dipterocarpaceae

Borneol microneedles (with iontophoresis) for enhanced brain and systemic drug absorption.

[34]

PHENOLIC COMPOUNDS:

1. Curcumin:

Curcumin, the main polyphenol in turmeric (Curcuma longa), exhibits potent antioxidant, anti-inflammatory, anticancer, and wound-healing properties. Despite poor bioavailability, advanced delivery systems like microneedles enhance absorption and therapeutic efficacy, making curcumin a promising natural therapeutic agent[.35-46]

2. Resveratrol:

Resveratrol, a natural polyphenol found in grapes, peanuts, and berries, exhibits antioxidant, anti-inflammatory, cardioprotective, and neuroprotective effects. Dissolving microneedle systems significantly enhance its solubility, bioavailability, and transdermal delivery for chronic disease treatment [47-57].

3. Carvacrol:

Carvacrol, a phenolic monoterpenoid from oregano and thyme, shows potent antimicrobial, anti-inflammatory, and antioxidant activity. Carvacrol-loaded microneedles improve solubility, stability, and wound healing through enhanced skin penetration and controlled release, offering promise for infection control and tissue repair [58,59,60].

4. Apigenin:

Apigenin, a flavonoid found in parsley and chamomile, shows antioxidant, anti-inflammatory, and dermatoprotective effects. It enhances skin barrier integrity, reduces cytokine-mediated inflammation, and relieves pruritus, making it useful in atopic dermatitis treatment [61,62].

5. Hypericin:

Hypericin, a bioactive compound from Hypericum perforatum, exhibits antidepressant, antiviral, and anticancer effects. Microneedle-assisted delivery enhances solubility, stability, and dermal penetration, improving photodynamic therapy efficacy for skin cancers and targeted treatments [63,64].

6. Epigallocatechin gallate (EGCG):

Epigallocatechin gallate (EGCG), a major green tea catechin, exhibits antioxidant, anti-inflammatory, and antimicrobial effects. Microneedle-assisted delivery enhances skin penetration, bioavailability, and therapeutic efficacy, showing promise in psoriasis, acne, hair regeneration, and oxidative stress-related skin disorders [65,66].

7. Celastrol (Ce):

Celastrol (Ce), a triterpenoid from Chinese medicinal herbs, exhibits antioxidant and anti-inflammatory effects. Microneedle-delivered Ce-loaded nanozymes enhance skin penetration, scavenge ROS, reduce cytokines, and alleviate psoriatic symptoms, offering a promising minimally invasive psoriasis therapy [67,68].

8. Polyphenol:

Polyphenols are plant-derived compounds with antioxidant, anti-inflammatory, and immunomodulatory effects. They promote wound healing, cardiovascular and neuroprotection, tissue regeneration, and mood regulation, offering a holistic therapeutic approach for oxidative stress and inflammation-related disorders [69,70].

9. Eugenol:

Eugenol is a phenolic compound from clove and other herbs, exhibiting antimicrobial, anti-inflammatory, analgesic, antioxidant, and local anesthetic effects. It is effective in dental care, wound healing, and biofilm-related infections, making it valuable for therapeutic use [71].

10. Mangiferin:

Mangiferin from Mangifera indica exhibits antioxidant, anti-inflammatory, antimicrobial, and pro-angiogenic effects. ROS/pH-responsive microneedle delivery enhances wound healing, biofilm eradication, and macrophage polarization, offering a promising precision therapy for infected wounds [72,73].

TABLE:4   Overview of Phenolic Compounds

Sr.No.

Phytoconstituents

Biological Source

Microneedle Application

References

1

Curcumin (Diferuloylmethane)

Curcuma longa (Turmeric rhizome, Zingiberaceae)

Nanosuspension-based dissolving MNs ↑ solubility, absorption, bioavailability; useful in skin disorders, inflammation, cancer.

[35-46]

 

2

Resveratrol (Res)

Polygonum cuspidatum, grapes, peanuts, mulberries, berries

PVP-based dissolving MNs (↑ solubility, 75% release/24h); hyaluronic acid MNs (anti-arthritic); SLN-MNs (Parkinson’s, sustained release, neuroprotection).

[47-57]

 

3

Carvacrol (monoterpenoid phenol)

Essential oils of thyme, oregano, marjoram, coriander

Nanoparticle-loaded dissolving MNs for wound healing; ↑ solubility, controlled release; accelerates closure, reduces infection, promotes angiogenesis.

[58,59,60]

4

Apigenin / Betanin

Petroselinum crispum (parsley), chamomile, celery, onions / Beta vulgaris (beetroot)

Hyaluronic acid MNs (rapid release, barrier repair, ↓ cytokines, atopic dermatitis); dissolvable MNs (sustained release, antioxidant, anticancer).

[61,62]

 

5

Hypericin (phenolic, anthraquinone)

Hypericum perforatum (St. John’s Wort)

MN patches enhance dermal delivery; improve PDT efficacy in skin cancers; hollow MNs superior to topical; also for viral & inflammatory disorders.

[63,64]

6

Epigallocatechin gallate (EGCG)

Camellia sinensis (green tea)

Dissolving MNs (PVA/HA-based); psoriasis therapy, hair regrowth (follicle activation), acne (↓ lipids, antibacterial, anti-inflammatory), wound healing.

[65,66]

 

7

Celastrol (triterpenoid)

Tripterygium wilfordii (Thunder God Vine)

Nanozyme-MNs (Ce@TA-Fe); mimic SOD/CAT enzymes, remove ROS; potent antioxidant/anti-inflammatory; effective in psoriasis (↓ PASI, keratinocytes).

[67,68]

8

Polyphenols (multiple phenolic compounds)

Fruits, vegetables, tea, coffee, cocoa, berries, Lycium barbarum

MNs enable antioxidant, anti-inflammatory, neuroprotective, wound-healing, cardiovascular protection; localized, controlled transdermal delivery.

[69,70]

9

Eugenol (allylbenzene phenolic)

Syzygium aromaticum (clove – main); also Ocimum sanctum, cinnamon, nutmeg, bay leaves

Incorporated into MN formulations for antimicrobial, antifungal, and biofilm disruption?109?; enhances wound healing and infection control?108?; applied in dental/oral MN patches for pain relief and antiseptic effects?110?; versatile phytoconstituent for herbal MN systems?111?.

[71]

10

Mangiferin (C-glucosylxanthone)

Mangifera indica L. (mango; family Anacardiaceae) – mainly in leaves, bark, fruit.

Dual ROS/pH-responsive MN system with PLGA microspheres + chitosan–gallic acid hydrogel + silver coating ; enables stimuli-responsive release in infected wounds; antibacterial action, ROS scavenging, macrophage M2 polarization, angiogenesis; enhances collagen deposition, re-epithelialization, and tissue regeneration; promising in wound infection management and antibiotic resistance.

[72,73]

TANNINS:

1. Catechin:

Catechin’s poor stability and bioavailability can be improved using microneedle arrays. PVA-based microneedles containing 10% gelatin microspheres showed the highest catechin release (84.4% at 24 h), demonstrating the effect of microsphere concentration on release kinetics [74].

2. Green Tea:

Green tea (Camellia sinensis) extract–loaded hyaluronic acid microneedles provide sustained antibacterial activity and promote wound healing. GT/HA microneedles achieved up to 95% bacterial growth reduction and enhanced wound closure, offering a biodegradable, effective alternative for infection control [75].

3. Pomegranate:

The nano-pomegranate millineedle platform integrates electrodynamic therapy, cuproptosis, and immune activation for oral cancer treatment. It enhances ROS generation, induces apoptosis, and suppresses tumor growth with minimal side effects, offering a multifunctional therapeutic strategy [76].

4. Grape:

Microneedle impedance sensors offer a non-destructive, real-time method to monitor grapevine water potential, enhancing irrigation efficiency and grape quality. This technique supports sustainable viticulture by optimizing water use and improving vineyard management practices [77].

5. Nuts:

Nuts are nutrient-rich foods offering cardioprotective, antioxidant, and anti-inflammatory benefits. Microneedle-based delivery of peanut allergens has shown potential for allergy desensitization, highlighting novel therapeutic applications beyond nutrition [78].

TABLE:5  Overview of Tannins

Sr.No.

Phytoconstituent

Biological Source

Microneedle Application

References

  1.  

Catechin

Green tea (Camellia sinensis), cocoa, fruits

Controlled catechin release (84.4% in 24 h) using gelatin microspheres

[74]

  1.  

Green Tea Extract (Catechins)

Leaves of Camellia sinensis

Antibacterial wound therapy, reducing infection

[75]

  1.  

Pomegranate (Punica granatum)

Family Lythraceae; cultivated in Mediterranean, Middle East

Oral cancer treatment using Pt@DLMSN + copper ionophore microneedles

[76]

  1.  

Grapes (Vitis vinifera)

Cultivated in Mediterranean, Europe

Monitoring grapevine water potential to optimize irrigation in viticulture

[77]

  1.  

Nuts

Almonds, walnuts, cashews, pistachios, peanuts (legume, but nutritionally considered nut)

Used in microneedle-based cutaneous immunotherapy with peanut allergens for allergy desensitization; potential role in immune modulation. Also provide systemic health benefits: cardioprotective, anti-inflammatory, antioxidant, glycemic control, BP regulation, weight management, longevity.

[78]

 

ALKALODS:

1. Nicotine:

Nicotine, an alkaloid from Nicotiana tabacum, is therapeutically used in Nicotine Replacement Therapy. Transdermal patches deliver nicotine steadily, reducing cravings and withdrawal symptoms, making them effective aids for smoking cessation [79].

2. Naloxone:

Naloxone, a semisynthetic opioid antagonist from Papaver somniferum, rapidly reverses opioid-induced respiratory depression. Hollow microneedle delivery achieves comparable or superior absorption to intramuscular injections, offering a faster, user-friendly option for overdose management [80].

3. Aconitum sinomontanum:

Microneedle-assisted nanostructured lipid carriers enhance transdermal delivery of Aconitum sinomontanum alkaloids, improving absorption, bioavailability, and analgesic and anti-inflammatory effects while reducing cardiotoxicity, offering a safe and effective strategy for clinical application [81].

4. Colchicine:

Colchicine, a tricyclic alkaloid from Colchicum autumnale, treats acute gout and inflammatory disorders. Microneedle-assisted transdermal delivery improves bioavailability and reduces gastrointestinal side effects, offering a safer, effective alternative to oral therapy [82].

5. Matrine, Oxymatrine:

Sophora flavescens contains alkaloids and flavonoids with anti-inflammatory, anticancer, antiviral, and immunomodulatory effects. Dissolving microneedle delivery enhances therapeutic efficacy, reduces systemic side effects, and offers promise for clinical applications such as psoriasis treatment [83].

6. Sinomenine:

PVP-based dissolving microneedles enable localized transdermal delivery of sinomenine, enhancing skin and systemic bioavailability, reducing gastrointestinal side effects, and improving therapeutic efficacy for rheumatoid arthritis compared to conventional gels or oral formulations [84].

7. Berberine:

Berberine-loaded liposomes-in-hydrogel microneedles enhance psoriasis treatment by bypassing the stratum corneum, providing controlled release, reducing inflammation, and improving skin penetration, offering a safe and effective alternative to conventional systemic or topical therapies [85].

8. Pilocarpine:

Dissolvable microneedle patches delivering pilocarpine provide a minimally invasive, effective alternative to iontophoresis for cystic fibrosis sweat testing, improving sweat yield, diagnostic accuracy, and tolerability, particularly in infants and resource-limited settings [86].

TABLE:6  Overview of Alkaloids

Sr No.

PHYTO-CONSTITUENTS

BIOLOGICAL SOURCE

MICRONEEDLE APPLICATION

References

1

Nicotine

Nicotiana tabacum (Tobacco)

Transdermal patches for Nicotine Replacement Therapy (NRT) – sustained release, reduced cravings

[79]

 

2

Naloxone

Semisynthetic (from Papaver somniferum via thebaine)

Hollow microneedles for opioid overdose reversal – rapid absorption, improved accessibility

[80]

3

Lappaconitine, Ranaconitine

Aconitum sinomontanum

MN-assisted NLCs for arthritis & inflammation – enhanced absorption, reduced cardiotoxicity

[81]

4

Colchicine

Colchicum autumnale (Autumn Crocus)

Transdermal MN delivery for gout and inflammatory diseases – improved safety and compliance

[82]

 

5

Matrine, Oxymatrine

Sophora flavescens

Dissolving MNs for psoriasis, cancer, asthma – localized delivery, reduced systemic toxicity

[83]

6

Sinomenine

Sinomenium acutum

PVP-based dissolving MNs for rheumatoid arthritis – better bioavailability, local action

[84]

7

Berberine

Berberis spp.

Transdermal MN delivery for gout and inflammatory diseases – improved safety and compliance

[85]

8

Pilocarpine

Pilocarpus jaborandi

Dissolving MN patches for sweat induction (CF diagnosis) – alternative to iontophoresis

[86]

CONCLUSION:

Microneedle technology offers a promising solution for herbal drug delivery by enhancing solubility, permeability, and bioavailability of phytoconstituents like curcumin, resveratrol, and mangiferin. It enables painless, controlled, and targeted transdermal delivery, improving therapeutic outcomes in various diseases. However, challenges in large-scale production, stability, and clinical validation persist. Continued multidisciplinary research and standardization are vital to translate this innovative approach into practical phytopharmaceutical therapies.

REFERENCES

  1. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–8.
  2. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–68.
  3. Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7(3):90–105.
  4. Wu C, Wu H, Yan Y, Lu T, Wang Y, Zhang Q, et al. Two-layered dissolving microneedles loaded with curcumin nanoparticles for synergistic chemo-photothermal therapy. J Control Release. 2024;358:105–18.
  5. Diao Z, Zheng Y, Li J, et al. Dual ROS/pH-responsive mangiferin-loaded microneedles for precision therapy of infected wounds. Mater Sci Eng C. 2025;150:114625.
  6. Gowda BHJ, Jayanthi S, Bhat R, et al. Microneedles as an emerging platform for transdermal delivery of phytochemicals: recent advances and challenges. Mol Pharm. 2024;21(5):1825–38.
  7. Wang M, Hu L, Xu C, Meng T, Dong H. Microneedles for transdermal delivery of natural products. J Control Release. 2022;350:749–68.
  8. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–8.
  9. Gowda BHJ, Jayanthi S, Bhat R, et al. Microneedles as an emerging platform for transdermal delivery of phytochemicals: recent advances and challenges. Mol Pharm. 2024;21(5):1825–38.
  10. Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7(3):90–105.
  11. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–68.
  12. Wu C, Wu H, Yan Y, Lu T, Wang Y, Zhang Q, et al. Two-layered dissolving microneedles loaded with curcumin nanoparticles for synergistic chemo-photothermal therapy. J Control Release. 2024;358:105–18.
  13. Xing B, Lu S, Wu Y, et al. Resveratrol nanocrystal-loaded dissolving microneedles for improved dermal delivery and therapeutic effect. Eur J Pharm Biopharm. 2024;193:75–84.
  14. Diao Z, Zheng Y, Li J, et al. Dual ROS/pH-responsive mangiferin-loaded microneedles for precision therapy of infected wounds. Mater Sci Eng C. 2025;150:114625.
  15. Cammarano A, Leino V, Trusso MA, et al. A systematic review of microneedle technology in drug delivery (2000–2023). Drug Deliv Transl Res. 2024;14(3):1021–40.
  16. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207.
  17. Wang M, Hu L, Xu C, Meng T, Dong H. Microneedles for transdermal delivery of natural products. J Control Release. 2022;350:749–68.
  18. Gowda BHJ, Jayanthi S, Bhat R, et al. Microneedles as an emerging platform for transdermal delivery of phytochemicals: recent advances and challenges. Mol Pharm. 2024;21(5):1825–38.
  19. Khorshidian A, Sharifi N, Choupani Kheirabadi F, Rezaei F, Sheikholeslami SA, Ariyannejad A, Esmaeili J, Basati H, Barati A. In vitro release of Glycyrrhiza glabra extract by a gel-based microneedle patch for psoriasis treatment. Gels. 2024;10(2):87.
  20. Chen Q, Wu C, Wang S, Wang Q, Wu P, Wang L, Yan P, Xie Y. Glycyrrhizic acid modified Poria cocos polysaccharide carbon dots dissolving microneedles for methotrexate delivery to treat rheumatoid arthritis. Front Chem. 2023;11:1181159.
  21. Yang Q, Guo P, Lei P, Yang Q, Liu Y, Tian Y, Shi W, Zhu C, Lei M, Zeng R, Zhang C, Qu Y. Dissolvable microneedles loaded ginsenoside Rg3 liposome: A transdermal delivery approach for alopecia treatment. Regen Biomater. 2024;11(1):rbae086. doi:10.1093/rb/rbae086.
  22. Gowda, R., Ghode, P., Manjunatha, M., Ravindran, R., Ghosh, D., & Hiremath, N. (2024). Microneedles as an emerging platform for transdermal delivery of phytochemicals. Journal of Drug Delivery Science and Technology, 88, 105655.
  23. Wang X, Zhao F, Wang X, Niu Y, Niu L, Wang C. Recent Advances in Nutrition for the Treatment of Depressive Disorder. Current Pharmaceutical Design. 2018 Oct 19;24(22):2583–90.
  24. Qothrunnadaa, T., & Hasanah, A. N. (2021). Patches for acne treatment: An update on the formulation and stability test. International Journal of Applied Pharmaceutics, 13(Special Issue 4), 21 26.
  25. Karumuri, S. R., Mohammed, H., Guha, K., Puli, A. K., Einsanwi, A., & Kondavitee, G. S. (2021). Design, simulation and analysis of micro electro?mechanical system microneedle for micropump in drug delivery systems. IET Nanobiotechnology, 15(5), 484–491.
  26. Yi Y, Yang Z, Zhou C, Yang Y, Wu Y, Zhang Q. Quercetin-encapsulated GelMa hydrogel microneedle reduces oxidative stress and facilitates wound healing. Nano TransMed. 2024 Dec;3:100030.
  27. Chen YJ, Cheng HW, Yen WY, Tsai JH, Yeh CY, Chen CJ, et al. The Treatment of Keloid Scars via Modulating Heterogeneous Gelatin-Structured Composite Microneedles to Control Transdermal Dual-Drug Release. Polymers [Internet]. 2022 Jan 1 [cited 2023 Oct 6];14(20):4436.
  28. Zhang Z, Li W, Chang D, Wei ZQ, Wang E, Yu J, et al. A combination therapy for androgenic alopecia based on quercetin and zinc/copper dual-doped mesoporous silica nanocomposite microneedle patch. 2023 Jun 1;24:81–95.
  29. Monsicha Khuanekkaphan, Kesinee Netsomboon, Adryan Fristiohady, Rathapon Asasutjarit. Development of Quercetin Solid Dispersion-Loaded Dissolving Microneedles and In Vitro Investigation of Their Anti-Melanoma Activities. Pharmaceutics. 2024 Sep 30;16(10):1276–6.
  30. Elsherbiny SA, ElKamel AH, Bakr BA, Heikal LA. Microneedle loaded with luteolin-colostrum-derived exosomes: a dropless approach for treatment of glaucoma. Drug Deliv Transl Res. 2025;1–21. DOI: 10.1007/s13346-025-01914-.
  31. Xia C, et al. NIR-II-responsive photothermal microneedle patch loaded with myricetin nanodrugs for the treatment of drug-resistant bacteria-infected wounds. Precis Med Eng. 2025;2:1–15.
  32. Journal of Controlled Release, Vol. 365, 2024, Article Title: "Oregano essential oil-infused mucin microneedle patch for the treatment of hypertrophic scar," Authors: Ayesha Younas, Muhammad Asad, Xiangling Wan, Yuzhen Zhang, Xuejing Ma, Lei Wang, Huan Gu, Hongtao Shang, Nan Zhang. Pages: 100–120
  33. Pharmaceutics, Vol. 14, 2022, Article Title: "Probing Pharmaceutical Strategies to Promote the Skin Delivery of Asiatic Acid from Hydrogels: Enhancement Effects of Organic Amine Counterions, Chemical Enhancers, and Microneedle Pretreatment," Authors: Li, M., Wang, Q., Chen, N., et al., Pages: 1–18
  34. International Journal of Pharmaceutics, Vol. 575, 2020, Article Title: "Increased microneedle mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention," Authors: Sirui Xiao, Yulu Yan et al., Pages: 1–10
  35. Abdelghany S, Tekko IA, Vora L, Larrañeta E, Permana AD, Donnelly RF. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics. 2019;11(7):308. doi:10.3390/pharmaceutics11070308
  36. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – a review. J Tradit Complement Med. 2017;7(2):205–233.
  37. Sonavane K, Phillips J, Ekshyyan O, Moore-Medlin T, Roberts Gill J, Rong X, et al. Topical curcumin-based cream is equivalent to dietary curcumin in a skin cancer model. J Skin Cancer. 2012;2012:147863.
  38. Nguyen TA, Friedman AJ. Curcumin: A novel treatment for skin-related disorders. J Drugs Dermatol. 2013;12(10):1131–1137.
  39. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895–2900.
  40. Gupta, S. C., Sung, B., Kim, J. H., Prasad, S., Li, S., & Aggarwal, B. B. (2013). Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports, 30(3), 394–419.
  41. Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92.
  42. Jurenka, J. S. (2009). Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Alternative Medicine Review, 14(2), 141–153.
  43. Menon, V. P., & Sudheer, A. R. (2007). Antioxidant and anti-inflammatory properties of curcumin. Advances in Experimental Medicine and Biology, 595, 105–125.
  44. Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2017). Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. British Journal of Pharmacology, 174(11), 1325–1348.
  45. Mishra, S., & Palanivelu, K. (2008). The effect of curcumin (turmeric) on Alzheimer’s disease: An overview. Annals of Indian Academy of Neurology, 11(1), 13–19.
  46. Akbik, D., Ghadiri, M., Chrzanowski, W., & Rohanizadeh, R. (2014). Curcumin as a wound healing agent. Advances in Wound Care, 3(8), 493–502.
  47. Tang H, Xiang S, Li X, Zhou J, Kuang C. Preparation and in vitro performance evaluation of resveratrol for oral self-microemulsion. PLoS One. 2019;14(04):e0214544.
  48. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261 1268.
  49. Dharadhar S, Majumdar A, Dhoble S, Patravale V. Microneedles for transdermal drug delivery: a systematic review. Drug Dev Ind Pharm. 2019;45(02):188–201.
  50. Xing B, Luo Q, Gan T, et al. Resveratrol-loaded dissolving microneedles: fabrication and in vitro evaluation. Pharmaceut Fronts. 2024;6:e439–e448.
  51. Pujara N, Jambhrunkar S, Wong KY, McGuckin M, Popat A. Enhanced colloidal stability, solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolate. J Colloid Interface Sci. 2017;488:303–308.
  52. Tosato MG, Maya Girón JV, Martin AA, Krishna Tippavajhala V, Fernández Lorenzo de Mele M, Dicelio L. Comparative study of transdermal drug delivery systems of resveratrol: high efficiency of deformable liposomes. Mater Sci Eng C. 2018;90:356–364.
  53. Cho S, Namkoong K, Shin M, et al. Cardiovascular protective effects and clinical applications of resveratrol. J Med Food. 2017;20(04):323–334.
  54. Nawaz W, Zhou Z, Deng S, et al. Therapeutic versatility of resveratrol derivatives. Nutrients. 2017;9(11):1188.
  55. Salehi B, et al. Resveratrol: A Double-Edged Sword in Health Benefits. Nutrients. 2018;10(11):1923. doi:10.3390/nu10111923.
  56. Zhang Y, et al. Resveratrol nanocrystals based dissolving microneedles with highly efficient for rheumatoid arthritis. Int J Pharm. 2024;654:123456. PMID: 38556538.
  57. Bandiwadekar A, Jose J, Gopan G, Augustin V, Ashtekar H, Khot KB. A novel approach for the treatment of Parkinson’s disease: Resveratrol-SLNs loaded microneedles patch. Int J Pharm. 2024. PMID: 38949746.
  58. M?czka W, Peyrat A, So?tys A, et al. Carvacrol — A Natural Phenolic Compound with a Broad Spectrum of Therapeutic Effects. Molecules. 2023;28(5):1-32.
  59. Mir M, Permana AD, Ahmed N, Khan GM, Rehman AU, Donnelly RF. Enhancement in site-specific delivery of carvacrol for potential treatment of infected wounds using infection responsive nanoparticles loaded into dissolving microneedles: A proof of concept study. Eur J Pharm Biopharm. 2020;150:138-149.
  60. Wu Y, Yang L, Shi G, et al. Carvacrol/cyclodextrin/ceria nanoparticle/hyaluronate hybrid microneedle for promoted diabetic wound healing through the modulation of microenvironment. Int J Biol Macromol. 2025; [epub ahead of print]:139126.
  61. Li X, Zhang Y, Chen L, et al. Apigenin ameliorates atopic dermatitis by regulating inflammatory cytokines and restoring skin barrier function. Int J Mol Sci. 2025;26(3):1452.
  62. Park JH, Lee CM, Kim JH, et al. Apigenin inhibits cytokine-induced inflammation and improves epidermal function in keratinocytes. Phytomedicine. 2020;79:153349.
  63. Gowda R, Inamdar GS, Chinnathambi A, et al. Microneedle-mediated transdermal delivery of hypericin for enhanced photodynamic therapy in skin cancer. Int J Pharm. 2024;654:123512.
  64. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv Transl Res. 2012;2(4):295–307.
  65. Gowda R, Inamdar GS, Chinnathambi A, et al. Microneedle-mediated delivery of epigallocatechin gallate for treatment of inflammatory skin diseases. Int J Pharm. 2024;654:123518.
  66. Jia Y, Ji L, Zhang S, et al. Epigallocatechin gallate: recent advances in skin applications and delivery systems. Front Pharmacol. 2022;13:946251.
  67. Yao C, Wang H, Zhang Y, et al. Celastrol-loaded nanozymes in dissolving microneedles for synergistic treatment of psoriasis. Adv Funct Mater. 2023;33(15):2301145.
  68. Gowda R, Inamdar GS, Chinnathambi A, et al. Microneedle-mediated transdermal delivery of antioxidant nanoformulations for psoriasis therapy. Int J Pharm. 2023;654:123509.
  69. Crews WD Jr, Harrison DW, Wright JW. A review of the neurocognitive effects of polyphenols in aging and neurodegenerative disease. Nutr Neurosci. 2016;19(10):1–12.
  70. Drevets WC, Burke TM, Rappaport LM, et al. Dietary polyphenols and their role in neuroprotection and mental health. Front Nutr. 2022;9:864321.
  71. Gowda R, Inamdar GS, Chinnathambi A, et al. Eugenol-based microneedle delivery systems for enhanced antimicrobial and wound-healing applications. Int J Pharm. 2024;654:123525.
  72. Daud N, Aung CS, Hewavitharana AK, et al. Mangiferin: a promising therapeutic agent for wound healing and inflammation. Phytother Res. 2010;24(9):1322–1331.
  73. Yang L, Wu Y, Shi G, et al. ROS/pH-responsive mangiferin-loaded microneedles for accelerated healing of infected wounds. Chem Eng J. 2023;475:146420.
  74. Sabbagh F, Muhamad II, Paidi SK, et al. Optimization of catechin-loaded PVA/gelatin microsphere microneedles for controlled transdermal delivery. Mater Sci Eng C. 2024;158:115091.
  75. Park JH, Lee JW, Kim YC, Prausnitz MR. Hyaluronic acid-based microneedles loaded with green tea extract for enhanced antibacterial activity and wound healing. Eur J Pharm Biopharm. 2014;88(3):888–896.
  76. Wan X, Li Y, Zhang Q, et al. Nano-pomegranate millineedle platform combining electrodynamic therapy, cuproptosis, and immune activation for synergistic oral cancer treatment. Adv Funct Mater. 2025;35(4):2411023.
  77. Zhang Y, Liu H, Chen W, et al. Microneedle impedance sensor for real-time monitoring of grapevine water potential to improve irrigation management. Biosens Bioelectron. 2025;239:116785.
  78. Shakya AK, Nandakumar KS. Peptide and allergen delivery via microneedles: a novel approach for peanut allergy immunotherapy. Eur J Pharm Biopharm. 2020;152:240–249.
  79. GSC Biological and Pharmaceutical Sciences. Therapeutic use of nicotine in smoking cessation through transdermal delivery systems. GSC Biol Pharm Sci. 2024;18(3):45–52.
  80. Papich MG, Narayan RJ. Hollow microneedle-mediated delivery of naloxone for rapid opioid overdose reversal. Adv Drug Deliv Rev. 2021;178:113957.
  81. Bhatnagar S, Dave K, Venuganti VVK. Microneedle-assisted transdermal delivery of Aconitum sinomontanum alkaloids using nanostructured lipid carriers: Improved bioavailability and reduced cardiotoxicity. Int J Pharm. 2017;531(1):350–362.
  82. Liu Y, Zhang H, Wang J, et al. Microneedle-mediated transdermal delivery of colchicine for enhanced bioavailability and reduced gastrointestinal toxicity. Eur J Pharm Sci. 2022;176:106263.
  83. Zhou Y, Li X, Chen J, et al. Dissolving microneedle-mediated transdermal delivery of Sophora flavescens extract for psoriasis therapy: Enhanced efficacy and reduced systemic toxicity. Int J Pharm. 2025;654:122487.
  84. Shu Z, Tan Q, Gui S, et al. PVP-based dissolving microneedles for enhanced transdermal delivery of sinomenine in rheumatoid arthritis therapy. Eur J Pharm Biopharm. 2020;157:45–55.
  85. Shen J, Wang L, Zhao Y, et al. Berberine-loaded liposomes-in-hydrogel microneedles for enhanced transdermal delivery and psoriasis therapy. Int J Pharm. 2025;655:122598.
  86. Li W, Terry RN, Tang J, et al. Dissolvable microneedle patches for pilocarpine delivery in cystic fibrosis sweat testing: Improved efficiency and patient comfort. Sci Transl Med. 2021;13(587):eaba5592.

Reference

  1. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–8.
  2. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–68.
  3. Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7(3):90–105.
  4. Wu C, Wu H, Yan Y, Lu T, Wang Y, Zhang Q, et al. Two-layered dissolving microneedles loaded with curcumin nanoparticles for synergistic chemo-photothermal therapy. J Control Release. 2024;358:105–18.
  5. Diao Z, Zheng Y, Li J, et al. Dual ROS/pH-responsive mangiferin-loaded microneedles for precision therapy of infected wounds. Mater Sci Eng C. 2025;150:114625.
  6. Gowda BHJ, Jayanthi S, Bhat R, et al. Microneedles as an emerging platform for transdermal delivery of phytochemicals: recent advances and challenges. Mol Pharm. 2024;21(5):1825–38.
  7. Wang M, Hu L, Xu C, Meng T, Dong H. Microneedles for transdermal delivery of natural products. J Control Release. 2022;350:749–68.
  8. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–8.
  9. Gowda BHJ, Jayanthi S, Bhat R, et al. Microneedles as an emerging platform for transdermal delivery of phytochemicals: recent advances and challenges. Mol Pharm. 2024;21(5):1825–38.
  10. Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7(3):90–105.
  11. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–68.
  12. Wu C, Wu H, Yan Y, Lu T, Wang Y, Zhang Q, et al. Two-layered dissolving microneedles loaded with curcumin nanoparticles for synergistic chemo-photothermal therapy. J Control Release. 2024;358:105–18.
  13. Xing B, Lu S, Wu Y, et al. Resveratrol nanocrystal-loaded dissolving microneedles for improved dermal delivery and therapeutic effect. Eur J Pharm Biopharm. 2024;193:75–84.
  14. Diao Z, Zheng Y, Li J, et al. Dual ROS/pH-responsive mangiferin-loaded microneedles for precision therapy of infected wounds. Mater Sci Eng C. 2025;150:114625.
  15. Cammarano A, Leino V, Trusso MA, et al. A systematic review of microneedle technology in drug delivery (2000–2023). Drug Deliv Transl Res. 2024;14(3):1021–40.
  16. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207.
  17. Wang M, Hu L, Xu C, Meng T, Dong H. Microneedles for transdermal delivery of natural products. J Control Release. 2022;350:749–68.
  18. Gowda BHJ, Jayanthi S, Bhat R, et al. Microneedles as an emerging platform for transdermal delivery of phytochemicals: recent advances and challenges. Mol Pharm. 2024;21(5):1825–38.
  19. Khorshidian A, Sharifi N, Choupani Kheirabadi F, Rezaei F, Sheikholeslami SA, Ariyannejad A, Esmaeili J, Basati H, Barati A. In vitro release of Glycyrrhiza glabra extract by a gel-based microneedle patch for psoriasis treatment. Gels. 2024;10(2):87.
  20. Chen Q, Wu C, Wang S, Wang Q, Wu P, Wang L, Yan P, Xie Y. Glycyrrhizic acid modified Poria cocos polysaccharide carbon dots dissolving microneedles for methotrexate delivery to treat rheumatoid arthritis. Front Chem. 2023;11:1181159.
  21. Yang Q, Guo P, Lei P, Yang Q, Liu Y, Tian Y, Shi W, Zhu C, Lei M, Zeng R, Zhang C, Qu Y. Dissolvable microneedles loaded ginsenoside Rg3 liposome: A transdermal delivery approach for alopecia treatment. Regen Biomater. 2024;11(1):rbae086. doi:10.1093/rb/rbae086.
  22. Gowda, R., Ghode, P., Manjunatha, M., Ravindran, R., Ghosh, D., & Hiremath, N. (2024). Microneedles as an emerging platform for transdermal delivery of phytochemicals. Journal of Drug Delivery Science and Technology, 88, 105655.
  23. Wang X, Zhao F, Wang X, Niu Y, Niu L, Wang C. Recent Advances in Nutrition for the Treatment of Depressive Disorder. Current Pharmaceutical Design. 2018 Oct 19;24(22):2583–90.
  24. Qothrunnadaa, T., & Hasanah, A. N. (2021). Patches for acne treatment: An update on the formulation and stability test. International Journal of Applied Pharmaceutics, 13(Special Issue 4), 21 26.
  25. Karumuri, S. R., Mohammed, H., Guha, K., Puli, A. K., Einsanwi, A., & Kondavitee, G. S. (2021). Design, simulation and analysis of micro electro?mechanical system microneedle for micropump in drug delivery systems. IET Nanobiotechnology, 15(5), 484–491.
  26. Yi Y, Yang Z, Zhou C, Yang Y, Wu Y, Zhang Q. Quercetin-encapsulated GelMa hydrogel microneedle reduces oxidative stress and facilitates wound healing. Nano TransMed. 2024 Dec;3:100030.
  27. Chen YJ, Cheng HW, Yen WY, Tsai JH, Yeh CY, Chen CJ, et al. The Treatment of Keloid Scars via Modulating Heterogeneous Gelatin-Structured Composite Microneedles to Control Transdermal Dual-Drug Release. Polymers [Internet]. 2022 Jan 1 [cited 2023 Oct 6];14(20):4436.
  28. Zhang Z, Li W, Chang D, Wei ZQ, Wang E, Yu J, et al. A combination therapy for androgenic alopecia based on quercetin and zinc/copper dual-doped mesoporous silica nanocomposite microneedle patch. 2023 Jun 1;24:81–95.
  29. Monsicha Khuanekkaphan, Kesinee Netsomboon, Adryan Fristiohady, Rathapon Asasutjarit. Development of Quercetin Solid Dispersion-Loaded Dissolving Microneedles and In Vitro Investigation of Their Anti-Melanoma Activities. Pharmaceutics. 2024 Sep 30;16(10):1276–6.
  30. Elsherbiny SA, ElKamel AH, Bakr BA, Heikal LA. Microneedle loaded with luteolin-colostrum-derived exosomes: a dropless approach for treatment of glaucoma. Drug Deliv Transl Res. 2025;1–21. DOI: 10.1007/s13346-025-01914-.
  31. Xia C, et al. NIR-II-responsive photothermal microneedle patch loaded with myricetin nanodrugs for the treatment of drug-resistant bacteria-infected wounds. Precis Med Eng. 2025;2:1–15.
  32. Journal of Controlled Release, Vol. 365, 2024, Article Title: "Oregano essential oil-infused mucin microneedle patch for the treatment of hypertrophic scar," Authors: Ayesha Younas, Muhammad Asad, Xiangling Wan, Yuzhen Zhang, Xuejing Ma, Lei Wang, Huan Gu, Hongtao Shang, Nan Zhang. Pages: 100–120
  33. Pharmaceutics, Vol. 14, 2022, Article Title: "Probing Pharmaceutical Strategies to Promote the Skin Delivery of Asiatic Acid from Hydrogels: Enhancement Effects of Organic Amine Counterions, Chemical Enhancers, and Microneedle Pretreatment," Authors: Li, M., Wang, Q., Chen, N., et al., Pages: 1–18
  34. International Journal of Pharmaceutics, Vol. 575, 2020, Article Title: "Increased microneedle mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention," Authors: Sirui Xiao, Yulu Yan et al., Pages: 1–10
  35. Abdelghany S, Tekko IA, Vora L, Larrañeta E, Permana AD, Donnelly RF. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics. 2019;11(7):308. doi:10.3390/pharmaceutics11070308
  36. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – a review. J Tradit Complement Med. 2017;7(2):205–233.
  37. Sonavane K, Phillips J, Ekshyyan O, Moore-Medlin T, Roberts Gill J, Rong X, et al. Topical curcumin-based cream is equivalent to dietary curcumin in a skin cancer model. J Skin Cancer. 2012;2012:147863.
  38. Nguyen TA, Friedman AJ. Curcumin: A novel treatment for skin-related disorders. J Drugs Dermatol. 2013;12(10):1131–1137.
  39. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895–2900.
  40. Gupta, S. C., Sung, B., Kim, J. H., Prasad, S., Li, S., & Aggarwal, B. B. (2013). Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports, 30(3), 394–419.
  41. Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92.
  42. Jurenka, J. S. (2009). Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Alternative Medicine Review, 14(2), 141–153.
  43. Menon, V. P., & Sudheer, A. R. (2007). Antioxidant and anti-inflammatory properties of curcumin. Advances in Experimental Medicine and Biology, 595, 105–125.
  44. Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2017). Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. British Journal of Pharmacology, 174(11), 1325–1348.
  45. Mishra, S., & Palanivelu, K. (2008). The effect of curcumin (turmeric) on Alzheimer’s disease: An overview. Annals of Indian Academy of Neurology, 11(1), 13–19.
  46. Akbik, D., Ghadiri, M., Chrzanowski, W., & Rohanizadeh, R. (2014). Curcumin as a wound healing agent. Advances in Wound Care, 3(8), 493–502.
  47. Tang H, Xiang S, Li X, Zhou J, Kuang C. Preparation and in vitro performance evaluation of resveratrol for oral self-microemulsion. PLoS One. 2019;14(04):e0214544.
  48. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261 1268.
  49. Dharadhar S, Majumdar A, Dhoble S, Patravale V. Microneedles for transdermal drug delivery: a systematic review. Drug Dev Ind Pharm. 2019;45(02):188–201.
  50. Xing B, Luo Q, Gan T, et al. Resveratrol-loaded dissolving microneedles: fabrication and in vitro evaluation. Pharmaceut Fronts. 2024;6:e439–e448.
  51. Pujara N, Jambhrunkar S, Wong KY, McGuckin M, Popat A. Enhanced colloidal stability, solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolate. J Colloid Interface Sci. 2017;488:303–308.
  52. Tosato MG, Maya Girón JV, Martin AA, Krishna Tippavajhala V, Fernández Lorenzo de Mele M, Dicelio L. Comparative study of transdermal drug delivery systems of resveratrol: high efficiency of deformable liposomes. Mater Sci Eng C. 2018;90:356–364.
  53. Cho S, Namkoong K, Shin M, et al. Cardiovascular protective effects and clinical applications of resveratrol. J Med Food. 2017;20(04):323–334.
  54. Nawaz W, Zhou Z, Deng S, et al. Therapeutic versatility of resveratrol derivatives. Nutrients. 2017;9(11):1188.
  55. Salehi B, et al. Resveratrol: A Double-Edged Sword in Health Benefits. Nutrients. 2018;10(11):1923. doi:10.3390/nu10111923.
  56. Zhang Y, et al. Resveratrol nanocrystals based dissolving microneedles with highly efficient for rheumatoid arthritis. Int J Pharm. 2024;654:123456. PMID: 38556538.
  57. Bandiwadekar A, Jose J, Gopan G, Augustin V, Ashtekar H, Khot KB. A novel approach for the treatment of Parkinson’s disease: Resveratrol-SLNs loaded microneedles patch. Int J Pharm. 2024. PMID: 38949746.
  58. M?czka W, Peyrat A, So?tys A, et al. Carvacrol — A Natural Phenolic Compound with a Broad Spectrum of Therapeutic Effects. Molecules. 2023;28(5):1-32.
  59. Mir M, Permana AD, Ahmed N, Khan GM, Rehman AU, Donnelly RF. Enhancement in site-specific delivery of carvacrol for potential treatment of infected wounds using infection responsive nanoparticles loaded into dissolving microneedles: A proof of concept study. Eur J Pharm Biopharm. 2020;150:138-149.
  60. Wu Y, Yang L, Shi G, et al. Carvacrol/cyclodextrin/ceria nanoparticle/hyaluronate hybrid microneedle for promoted diabetic wound healing through the modulation of microenvironment. Int J Biol Macromol. 2025; [epub ahead of print]:139126.
  61. Li X, Zhang Y, Chen L, et al. Apigenin ameliorates atopic dermatitis by regulating inflammatory cytokines and restoring skin barrier function. Int J Mol Sci. 2025;26(3):1452.
  62. Park JH, Lee CM, Kim JH, et al. Apigenin inhibits cytokine-induced inflammation and improves epidermal function in keratinocytes. Phytomedicine. 2020;79:153349.
  63. Gowda R, Inamdar GS, Chinnathambi A, et al. Microneedle-mediated transdermal delivery of hypericin for enhanced photodynamic therapy in skin cancer. Int J Pharm. 2024;654:123512.
  64. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv Transl Res. 2012;2(4):295–307.
  65. Gowda R, Inamdar GS, Chinnathambi A, et al. Microneedle-mediated delivery of epigallocatechin gallate for treatment of inflammatory skin diseases. Int J Pharm. 2024;654:123518.
  66. Jia Y, Ji L, Zhang S, et al. Epigallocatechin gallate: recent advances in skin applications and delivery systems. Front Pharmacol. 2022;13:946251.
  67. Yao C, Wang H, Zhang Y, et al. Celastrol-loaded nanozymes in dissolving microneedles for synergistic treatment of psoriasis. Adv Funct Mater. 2023;33(15):2301145.
  68. Gowda R, Inamdar GS, Chinnathambi A, et al. Microneedle-mediated transdermal delivery of antioxidant nanoformulations for psoriasis therapy. Int J Pharm. 2023;654:123509.
  69. Crews WD Jr, Harrison DW, Wright JW. A review of the neurocognitive effects of polyphenols in aging and neurodegenerative disease. Nutr Neurosci. 2016;19(10):1–12.
  70. Drevets WC, Burke TM, Rappaport LM, et al. Dietary polyphenols and their role in neuroprotection and mental health. Front Nutr. 2022;9:864321.
  71. Gowda R, Inamdar GS, Chinnathambi A, et al. Eugenol-based microneedle delivery systems for enhanced antimicrobial and wound-healing applications. Int J Pharm. 2024;654:123525.
  72. Daud N, Aung CS, Hewavitharana AK, et al. Mangiferin: a promising therapeutic agent for wound healing and inflammation. Phytother Res. 2010;24(9):1322–1331.
  73. Yang L, Wu Y, Shi G, et al. ROS/pH-responsive mangiferin-loaded microneedles for accelerated healing of infected wounds. Chem Eng J. 2023;475:146420.
  74. Sabbagh F, Muhamad II, Paidi SK, et al. Optimization of catechin-loaded PVA/gelatin microsphere microneedles for controlled transdermal delivery. Mater Sci Eng C. 2024;158:115091.
  75. Park JH, Lee JW, Kim YC, Prausnitz MR. Hyaluronic acid-based microneedles loaded with green tea extract for enhanced antibacterial activity and wound healing. Eur J Pharm Biopharm. 2014;88(3):888–896.
  76. Wan X, Li Y, Zhang Q, et al. Nano-pomegranate millineedle platform combining electrodynamic therapy, cuproptosis, and immune activation for synergistic oral cancer treatment. Adv Funct Mater. 2025;35(4):2411023.
  77. Zhang Y, Liu H, Chen W, et al. Microneedle impedance sensor for real-time monitoring of grapevine water potential to improve irrigation management. Biosens Bioelectron. 2025;239:116785.
  78. Shakya AK, Nandakumar KS. Peptide and allergen delivery via microneedles: a novel approach for peanut allergy immunotherapy. Eur J Pharm Biopharm. 2020;152:240–249.
  79. GSC Biological and Pharmaceutical Sciences. Therapeutic use of nicotine in smoking cessation through transdermal delivery systems. GSC Biol Pharm Sci. 2024;18(3):45–52.
  80. Papich MG, Narayan RJ. Hollow microneedle-mediated delivery of naloxone for rapid opioid overdose reversal. Adv Drug Deliv Rev. 2021;178:113957.
  81. Bhatnagar S, Dave K, Venuganti VVK. Microneedle-assisted transdermal delivery of Aconitum sinomontanum alkaloids using nanostructured lipid carriers: Improved bioavailability and reduced cardiotoxicity. Int J Pharm. 2017;531(1):350–362.
  82. Liu Y, Zhang H, Wang J, et al. Microneedle-mediated transdermal delivery of colchicine for enhanced bioavailability and reduced gastrointestinal toxicity. Eur J Pharm Sci. 2022;176:106263.
  83. Zhou Y, Li X, Chen J, et al. Dissolving microneedle-mediated transdermal delivery of Sophora flavescens extract for psoriasis therapy: Enhanced efficacy and reduced systemic toxicity. Int J Pharm. 2025;654:122487.
  84. Shu Z, Tan Q, Gui S, et al. PVP-based dissolving microneedles for enhanced transdermal delivery of sinomenine in rheumatoid arthritis therapy. Eur J Pharm Biopharm. 2020;157:45–55.
  85. Shen J, Wang L, Zhao Y, et al. Berberine-loaded liposomes-in-hydrogel microneedles for enhanced transdermal delivery and psoriasis therapy. Int J Pharm. 2025;655:122598.
  86. Li W, Terry RN, Tang J, et al. Dissolvable microneedle patches for pilocarpine delivery in cystic fibrosis sweat testing: Improved efficiency and patient comfort. Sci Transl Med. 2021;13(587):eaba5592.

Photo
Dr. Jeevan Dhumal
Corresponding author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Ankita Bankar
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Aishwarya Botre
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Dhiraj Jankar
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Akshada Shinde
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Pranali Dhole
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Shruti Garde
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Ritesh Awate
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Dr. Archana Thikekar
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Suhas Ghodekar
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Dr. Amol Kumbhar
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Photo
Dr. Jyoti Kadam
Co-author

RJSPMs College of Pharmacy, Dudulgaon, Pune, Maharashtra, India.

Dr. Jeevan Dhumal, Suhas Ghodekar, Dhiraj Jankar, Aishwarya Botre, Ankita Bankar, Akshada Shinde, Ritesh Awate, Dr. Amol Kumbhar, Dr. Archana Thikekar, Dr. Jyoti Kadam, Herbal Extract and Phytoconstituents Delivered by Microneedle, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 2588-2603. https://doi.org/10.5281/zenodo.20127787

More related articles
Anti-Cholinesterase Drugs and Its Effects in Alzhe...
A. R. Shreya, Dr. A.V. Kishore Babu, Dr. A. Srinivasa Roa, Dr. J....
Brief Outline and Case Study of Ectopic Pregnancy ...
Pratiksha Sanjay Gadade , Arjun Shivaji Rathod , ...
Unravelling Acne Vulgaris: A Comprehensive Review ...
Piyush Lekhraj Yadav, Prajakta Dattatraya Gawade, Manasi Vishwas ...
Nanocosmeceutical and Emerging Trends in Pharmacy...
Sharda Gaikwad , Pranali Karande, Rani Chavan , Dr. Sadhana Shahi, ...
Formulation and Evaluation of a Polyherbal Anti-Inflammatory Functional Candy C...
Neha Chaudhari, Sandeep Mukati, Nivesh Pratap Singh Gurjar, Sudha Vengurlekar, ...
Related Articles
Treatment of Postpartum Depression: Clinical and Pharmacological Options ...
Kapil Shinde , Samarth Lande , Vishvambar Raut, Vaishnavi Shinde, ...
Formulation And Evaluation of Herbal Essential Oil-Based Nail Lacquer for Manage...
Anjali Bawaskar, Vishal Keshewar, Pallavi Korde, Komal Pathade, Dr. Shivashankar Mhaske, Vinod Chawa...
Formulation and Evaluation of Herbal Arthritis Oil for Joint Pain Relief Using A...
Sandesh Siddheshwar, Mahadik Maya, Dr. Garje Sanjay, Dr. Sayyad Gaffar, ...
Formulation Development and Evaluation of Clotrimazole Buccal Tablets ...
Mohammad Azmath Hussain, Dr. Sreenivas Rao Mande, Dr. G. Kumara Swamy, Dr. D Praveen Kumar, Dr. J Ku...
Anti-Cholinesterase Drugs and Its Effects in Alzheimer Disease, And Its Impacts ...
A. R. Shreya, Dr. A.V. Kishore Babu, Dr. A. Srinivasa Roa, Dr. J. V. Manisha Vajra, ...
More related articles
Anti-Cholinesterase Drugs and Its Effects in Alzheimer Disease, And Its Impacts ...
A. R. Shreya, Dr. A.V. Kishore Babu, Dr. A. Srinivasa Roa, Dr. J. V. Manisha Vajra, ...
Brief Outline and Case Study of Ectopic Pregnancy ...
Pratiksha Sanjay Gadade , Arjun Shivaji Rathod , ...
Unravelling Acne Vulgaris: A Comprehensive Review of Epidemiology, Pathogenesis,...
Piyush Lekhraj Yadav, Prajakta Dattatraya Gawade, Manasi Vishwas Shelke , Rahul Rakesh Vishwakarma, ...
Anti-Cholinesterase Drugs and Its Effects in Alzheimer Disease, And Its Impacts ...
A. R. Shreya, Dr. A.V. Kishore Babu, Dr. A. Srinivasa Roa, Dr. J. V. Manisha Vajra, ...
Brief Outline and Case Study of Ectopic Pregnancy ...
Pratiksha Sanjay Gadade , Arjun Shivaji Rathod , ...
Unravelling Acne Vulgaris: A Comprehensive Review of Epidemiology, Pathogenesis,...
Piyush Lekhraj Yadav, Prajakta Dattatraya Gawade, Manasi Vishwas Shelke , Rahul Rakesh Vishwakarma, ...